BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song J, Patel RV, Sharif M, Ashokan A, Michaelides M. Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders. Mol Ther 2021:S1525-0016(21)00636-5. [PMID: 34861415 DOI: 10.1016/j.ymthe.2021.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferrari LL, Ogbeide-Latario OE, Gompf HS, Anaclet C. Validation of DREADD agonists and administration route in a murine model of sleep enhancement. J Neurosci Methods 2022;380:109679. [PMID: 35914577 DOI: 10.1016/j.jneumeth.2022.109679] [Reference Citation Analysis]
2 Kim S, Nam Y, Kim HS, Jung H, Jeon SG, Hong SB, Moon M. Alteration of Neural Pathways and Its Implications in Alzheimer’s Disease. Biomedicines 2022;10:845. [DOI: 10.3390/biomedicines10040845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]